About Clear Vascular
Clear Vascular was a Healthcare company based in The Woodlands (United States) founded in 2005. It develops pharmaceutical products for treating cardiovascular conditions. It operates on a B2B model. Clear Vascular has raised $3.16 million across 5 funding rounds from investors including OSTI.GOV. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Development and Cardiovascular Treatments. Its competitors include Mercurius Health, Niowave, Mediso, PETsys Electronics and Cubresa and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Clear Vascular, established in 2005, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and cardiovascular treatments. Develops pharmaceutical products for treating cardiovascular conditions. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters The Woodlands, United States
- SectorsHealthcare
- Website clearvascular.com
- Total Equity Funding$3.16M (USD)
in 5 rounds
- Latest Funding Round$309.41K (USD), Seed
May 2013
- Investors
Funding Insights of Clear Vascular
Clear Vascular has successfully raised a total of $3.16M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $309.41 thousand completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.16M
- Total Rounds 5
- Last Round Seed — $309,408
- First Round $500,000
(Sep 2009)
- Investors Count 1
All 5 funding rounds of Clear Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2013 | $309,408 | Seed | – | – | – |
| Oct 2012 | $1M | Seed | – | – | – |
| Feb 2012 | $1.14M | Grant | – | – | |
| Jul 2010 | $1.35M | Seed | – | – | – |
| Sep 2009 | $500,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Clear Vascular
Clear Vascular has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | osti.gov | - |
Investor details for Clear Vascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Clear Vascular
3 dated milestones of Clear Vascular across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Clear Vascular is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Seed, of $309K.
Competitors of Clear Vascular
Clear Vascular has 9 listed competitors in our database, 3 of them funded. They include Mercurius Health, Niowave, Mediso, PETsys Electronics and Cubresa, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mercuriushealth.com | 2013 | Porto Salvo, Portugal | – | – | Resources and training for radiotherapy and nuclear medicine are provided. | |
| niowaveinc.com | 2006 | United States | $9.95M | – | Devices and radioisotopes for nuclear imaging are provided by Niowave. | |
| mediso.com | 1990 | Budapest, Hungary | – | – | Nuclear medicine and hybrid imaging equipment | |
| petsyselectronics.com | 2013 | Oeiras, Portugal | – | – | Gamma ray detectors are developed for medical PET scanners. | |
| cubresa.com | 2011 | Winnipeg, Canada | $4.5M | – | Nuclear imaging products | |
| cmr-naviscan.com | 2003 | Carlsbad, United States | – | – | High-resolution PET systems for breast cancer imaging are provided. | |
| bestcyclotron.com | 2009 | – | – | – | Provides comprehensive design and production solutions for commercial cyclotrons. | |
| seraclifesciences.com | 2017 | London, United Kingdom | $2.04M | – | Molecular imaging devices are developed for arthritis diagnostics. | |
| gmisotope.com | 2013 | Henderson, United States | – | – | Specializes in medical isotope production and specialty metal processing. |
Detailed competitors of Clear Vascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Clear Vascular (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clear Vascular
Complete news archive for Clear Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clear Vascular
Clear Vascular was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Clear Vascular is headquartered in The Woodlands, United States. It is registered at The Woodlands, Texas, United States.
Clear Vascular is a funded company, having raised a total of $3.16M across 5 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Sep 2009.
Clear Vascular, established in 2005, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and cardiovascular treatments. Develops pharmaceutical products for treating cardiovascular conditions. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Clear Vascular has 1 investor. Key investors include OSTI.GOV.